跳轉至內容
Merck
全部照片(2)

文件

HLPPMAG-57K

Millipore

MILLIPLEX® 人肝蛋白磁珠板 - 代谢多重检测

The Human Liver Protein Panel, using the Luminex xMAP technology, enables the simultaneous analysis of 9 liver protein biomarkers in human serum, plasma and tissue/cell culture samples.

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12161503
eCl@ss:
32161000
NACRES:
NA.47

品質等級

物種活性

human

製造商/商標名

Milliplex®

assay range

accuracy: 100.2%
(HGF)

accuracy: 93.7%
(ANGPTL3)

accuracy: 94.2%
(AFP)

accuracy: 96.6%
(FGF-23)

accuracy: 96.8%
(ANGPTL4)

accuracy: 98.8%
(FGF-21)

sensitivity: 0.004 ng/mL
(MinDC+2SD; FGF-21)

sensitivity: 0.014 ng/mL
(MinDC+2SD; FGF-23)

sensitivity: 0.018 ng/mL
(MinDC+2SD; HGF)

sensitivity: 0.054 ng/mL
(MinDC+2SD; FGF-19)

sensitivity: 0.144 ng/mL
(MinDC+2SD; AFP)

sensitivity: 0.218 ng/mL
(MinDC+2SD; FABP1)

sensitivity: 0.725 ng/mL
(MinDC+2SD; ANGPTL3)

sensitivity: 0.847 ng/mL
(MinDC+2SD; ANGPTL6)

sensitivity: 2.150 ng/mL
(MinDC+2SD; ANGPTL4)

standard curve range: 0.01-10 ng/mL
(FGF-21)

standard curve range: 0.04-30 ng/mL
(FGF-23)

standard curve range: 0.07-50 ng/mL
(HGF)

standard curve range: 0.14-100 ng/mL
(AFP)

standard curve range: 0.14-100 ng/mL
(FGF-19)

standard curve range: 0.27-200 ng/mL
(FABP1)

standard curve range: 0.69-500 ng/mL
(ANGPTL3)

standard curve range: 1.37-1000 ng/mL
(ANGPTL6/AGF)

standard curve range: 5.49-4000 ng/mL
(ANGPTL4)

inter-assay cv: <20%
intra-assay cv: <10%
(AFP)

inter-assay cv: <20%
intra-assay cv: <10%
(ANGPTL3)

inter-assay cv: <20%
intra-assay cv: <10%
(ANGPTL4)

inter-assay cv: <20%
intra-assay cv: <10%
(ANGPTL6/AGF)

inter-assay cv: <20%
intra-assay cv: <10%
(FABP1)

inter-assay cv: <20%
intra-assay cv: <10%
(FGF-19)

inter-assay cv: <20%
intra-assay cv: <10%
(FGF-21)

inter-assay cv: <20%
intra-assay cv: <10%
(FGF-23)

inter-assay cv: <20%
intra-assay cv: <10%
(HGF)

技術

multiplexing: suitable

檢測方法

fluorometric (Luminex xMAP)

運輸包裝

wet ice

一般說明

肝分泌蛋白通过调节循环脂蛋白水平,能量消耗,葡萄糖代谢和脂肪酸摄取,在代谢稳态中发挥重要作用。肝脏分泌的蛋白质可以作为肝脏疾病和胃癌的生物标志物。肝蛋白的准确测量对于了解其生物学功能至关重要。

MILLIPLEX®人肝蛋白检测试剂盒是一种9重试剂盒,用于同时定量血清、血浆和组织/细胞培养样本中以下分析物的任何或全部:AFP,ANGPTL3,ANGPTL4,ANGPTL6/AGF,FABP1/L-FABP,FGF-19,FGF-21,FGF-23和HGF。

注:当测定ANGPTL6/AGF时,建议使用血清样品。

该试剂盒采用96孔板,包含冻干标准混合物、两个内部检测质控品,可最多可测定38份样本,重复两次。

Luminex® xMAP®平台使用磁珠免疫分析格式,以实现理想的速度和灵敏度,同时定量多种分析物,从而显著提高生产力,同时节省宝贵的样本量。

面板类型:代谢

特異性

交叉反应
ANGPTL6标准品与ANGPTL4分析的交叉反应性小于2%。 对于全部其他分析物,一种分析物的抗体与本检测条中的任何其他分析物之间不存在或可忽略的交叉反应性。

應用

  • 分析物:α-甲胎蛋白(AFP)、ANGPTL3、ANGPTL4、ANGPTL6(AGF)、FABP1(L-FABP)、FGF-19、FGF-21、FGF-23、HGF
  • 推荐样本类型: 人血清、血浆和细胞/组织培养上清液或裂解液
  • 注释:测量ANGPTL6/AGF时建议使用血清样品
  • 推荐的样品稀释度:每孔12.5 μL 1:2稀释的血清或血浆。细胞/组织培养样品可以未经稀释或在对照培养基中适当稀释使用。
  • 分析运行时间:为了获得最佳灵敏度,建议在2-8℃下过夜(16-18小时)。也可以在室温(20-25℃)下使用2小时。
  • 研究类别:代谢
  • 研究子类别:代谢紊乱

特點和優勢

通过在此面板中选择可用的分析物来设计多重试剂盒。

包裝

96孔板
单个试剂盒即可满足您的所有需求。

儲存和穩定性

试剂盒组分建议的存储温度为2-8°C。

其他說明

请联系技术服务部进行稀释度线性研究。

法律資訊

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

象形圖

Skull and crossbonesEnvironment

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Manjunath Ramanjaneya et al.
Frontiers in endocrinology, 11, 568500-568500 (2020-10-27)
Background: The fibroblast growth factors (FGF) 19 subfamily, also referred to as endocrine FGFs, includes FGF19, FGF21, and FGF23 are metabolic hormones involved in the regulation of glucose and lipid metabolism. Fetuin-A is a hepatokine involved in the regulation of
Nigel Davies et al.
Molecular therapy. Nucleic acids, 24, 369-384 (2021-04-20)
Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous and intramuscular administration. Subcutaneous administration opens the possibility of patient self-administration and hence long-term chronic treatment that could enable messenger
Stefano Bartesaghi et al.
Molecular therapy. Nucleic acids, 28, 500-513 (2022-05-21)
Fibroblast growth factor 21 (FGF21) is a promising therapeutic agent for treatment of type 2 diabetes (T2D) and non-alcoholic steatohepatitis (NASH). We show that therapeutic levels of FGF21 were achieved following subcutaneous (s.c.) administration of mRNA encoding human FGF21 proteins.
Imad Tarhoni et al.
Journal of immunoassay & immunochemistry, 39(1), 84-98 (2018-01-09)
Angiogenesis is associated with tumor progression in a range of malignancies. Herein, we develop custom immunobead assays for several mechanistically important targets and evaluated these against sera from cohorts of non-small cell lung cancer (NSCLC) patients. Antigen "capture" antibodies for

相關內容

UnEnhance research with MILLIPLEX® multiplexing tips, industry guidance, and one-day assays for limited lab time.

Multiplex immunoassays save time and sample volume in metabolic syndrome research, providing comprehensive insights into related conditions.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務